Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 1, 2002, Pages 156-162

  Cheng, Jason Chia Hsien ^a   Wu, Jian Kuen ^a   Huang, Chao Ming ^a   Liu, Hua Shan ^a   Huang, David Y ^a   Cheng, Skye Hongiun ^a,c   Tsai, Stella Y ^a,c   Jian, James Jer Min ^a,c   Lin, Yu Mong ^a   Cheng, Tsun I ^a   Horng, Cheng Fang ^a,b   Huang, Andrew T ^a,c  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatocellular carcinoma; Normal tissue complication probability; Radiation induced liver disease; Three dimensional conformal radiotherapy

Indexed keywords

IRRADIATION; PATIENT MONITORING; RADIATION; TOXICITY;

HISTOGRAM ANALYSIS;

ONCOLOGY;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; COMPUTER ASSISTED RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOSIMETRY; FEMALE; HISTOGRAM; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING; TUMOR VOLUME; VIRUS HEPATITIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROBABILITY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 0036719951     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02915-2     Document Type: Article

References (38)

1. Hepatocellular cancers treated by radiation and chemotherapy combinations: Toxicity and response - A Radiation Therapy Oncology Group study
2. Technical considerations in the use of 3-D beam arrangements in the abdomen
3. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers
4. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma
5. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization
6. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies
7. Hepatic toxicity resulting from cancer treatment
8. The human liver after radiation injury
9. The use of 3-D dose volume analysis to predict radiation hepatitis
10. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model
11. Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: Analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy
12. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy
13. Complication probability as assessed from dose volume histograms
14. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method
15. Common Toxicity Criteria, version 2.0: An improved reference for grading the acute effects of cancer treatment - Impact on radiotherapy
16. The delay before onset of accelerated tumour cell repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection of worldwide tumour-control data
17. Fitting of normal tissue tolerance data to an analytic function
18. Radiation hepatitis
19. Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique
20. Hepatic injury following irradiation - A morphologic study
21. High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis
22. The triple phase CT image appearance of post-irradiated livers
23. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy
24. The usefulness of radiation therapy for hepatocellular carcinoma
25. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma
26. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers
27. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model
28. Description of radiation induced liver disease using Lyman and local damage-organ injury NTCP models
29. Tolerance of normal tissue to therapeutic irradiation
30. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model
31. Partial irradiation of the liver
32. Hepatic resection in 120 patients with hepatocellular carcinoma
33. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A comparison of epirubicin and doxorubicin (second cooperative study)
34. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: A phase II trial of the Puget Sound Oncology Consortium (PSOC 1104)
35. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma